Guaifenesin D Tablet, Extended Release
Product Images NDC 0536-1333

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin D (NDC 0536-1333). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rugby Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (36 Tablet Blister Pack Carton)

This is a drug information label for Guaifenesin and Pseudoephedrine HCI Extended-Release Tablets. It contains information about the active ingredients, purpose, dosage, warnings, and other related information. The tablets combine guaifenesin and pseudoephedrine HCI to provide relief from nasal/sinus congestion, thin and loosen mucus, and suppress coughs in adults and children aged 12 years and above. It comes in a 12-hour extended-release tablet form. The text appears to be readable and understandable.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.